Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study
Objective: Programmed cell death ligand-1 interacts with the immune receptors on the surface of CD8+ tumor infiltrating lymphocytes and PD-1, thereby blocking its anti-tumor activity. Therapeutics suppression of this interaction will show a promise in the treatment of non-small cell lung cancer by r...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Federation of Turkish Pathology Societies
2017-09-01
|
Series: | Türk Patoloji Dergisi |
Subjects: | |
Online Access: | http://www.turkjpath.org/pdf.php3?id=1834 |